Noemi Fusaki

Actin tyrosine dephosphorylation by the Src homology 1-containing protein tyrosine phosphatase is essential for actin depolymerization after membrane IgM cross-linking.

Myosin is an in vivo substrate of the protein tyrosine phosphatase (SHP-1) after mIgM cross-linking.

CD72 stimulation modulates anti-IgM induced apoptotic signaling through the pathway of NF-kappaB, c-Myc and p27(Kip1).

Dual regulation of BCR-mediated growth inhibition signaling by CD72.

Identification of HLA-A2- and A24-restricted T-cell epitopes derived from SOX6 expressed in glioma stem cells for immunotherapy.

Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome.

Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells.

Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors.

Downregulation of KIF23 suppresses glioma proliferation.

Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells.

Generation of virus-free induced pluripotent stem cell clones on a synthetic matrix via a single cell subcloning in the naïve state.

Pathogenic mutation of ALK2 inhibits induced pluripotent stem cell reprogramming and maintenance: mechanisms of reprogramming and strategy for drug identification.

Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes.

Generation of human induced pluripotent stem cells from cord blood cells.

Blood cell-derived induced pluripotent stem cells free of reprogramming factors generated by Sendai viral vectors.

Effect of in vivo administration of reprogramming factors in the mouse liver.

Induced pluripotent stem cell reprogramming by integration-free Sendai virus vectors from peripheral blood of patients with craniometaphyseal dysplasia.

Human iPSC-based modeling of late-onset disease via progerin-induced aging.

Generation of familial amyloidotic polyneuropathy-specific induced pluripotent stem cells.

New type of Sendai virus vector provides transgene-free iPS cells derived from chimpanzee blood.

Derivation of iPSCs after culture of human dental pulp cells under defined conditions.

HPGCD outperforms HPBCD as a potential treatment for Niemann-Pick disease type C during disease modeling with iPS cells.

Brief report: isogenic induced pluripotent stem cell lines from an adult with mosaic down syndrome model accelerated neuronal ageing and neurodegeneration.

Generation of a High Number of Healthy Erythroid Cells from Gene-Edited Pyruvate Kinase Deficiency Patient-Specific Induced Pluripotent Stem Cells.

Plastin 3 is upregulated in iPSC-derived motoneurons from asymptomatic SMN1-deleted individuals.

Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.

Reprogramming of Melanoma Tumor-Infiltrating Lymphocytes to Induced Pluripotent Stem Cells.